Medicare Enrolled
Dr. Maen Hussein, M.D.
Hematology · Lady Lake, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hussein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hussein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hussein
Dr. Maen Hussein is a hematology specialist in Lady Lake, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hussein performed 342,147 Medicare services across 8,728 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hussein received a total of $179,385 from 110 pharmaceutical and/or device companies across 1340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hussein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in FL
$179,385 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 96921 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗342,147
Medicare services
Top 6% in FL for hematology
8,728
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,107 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
75,480 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
57,300 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 26,200 | $43 | $137 |
| Paclitaxel chemotherapy injection | 25,364 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 24,570 | $1 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
20,400 | $0 | $5 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
15,840 | $38 | $110 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
15,700 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 12,660 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
9,720 | $6 | $23 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
7,963 | $0 | $3 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
7,756 | $36 | $108 |
| Injection, docetaxel, 1 mg | 6,558 | $1 | $7 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
5,605 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
5,364 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,160 | $1 | $28 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,707 | $65 | $239 |
| Iron infusion (Monoferric) | 2,600 | $17 | $57 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
2,464 | $23 | $185 |
| Anti-nausea injection (ondansetron/Zofran) | 1,776 | $0 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,346 | $96 | $339 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,285 | $10 | $69 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,211 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
1,201 | $97 | $378 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
865 | $2 | $41 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 610 | $3 | $205 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
563 | $46 | $189 |
| Injection, leucovorin calcium, per 50 mg | 545 | $3 | $12 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
533 | $1 | $6 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
415 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
373 | $21 | $79 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
356 | $49 | $178 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
353 | $2 | $7 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
341 | $22 | $84 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
321 | $7 | $69 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
239 | $15 | $56 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
222 | $10 | $42 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
163 | $27 | $156 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
136 | $24 | $89 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
136 | $128 | $453 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
136 | $17 | $59 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
134 | $54 | $206 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
120 | $101 | $377 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
114 | $2 | $8 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
109 | $2 | $7 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
103 | $4 | $15 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
82 | $42 | $170 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 79 | $132 | $562 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
78 | $3 | $11 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
72 | $1 | $7 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
69 | $39 | $109 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
60 | $24 | $156 |
| Radiation therapy, 3+ areas, 6-10 MeV Radiation treatment delivered to three or more separate areas using advanced techniques like custom blocking and rotational beams with an energy level of 6-10 MeV. |
59 | $176 | $587 |
| CT guidance for radiation therapy This procedure uses computed tomography imaging to guide the precise placement of radiation therapy fields. It ensures accurate positioning for targeted treatment delivery. |
57 | $57 | $300 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
57 | $270 | $1,100 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
53 | $4 | $10 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
50 | $63 | $197 |
| Stereoscopic X-ray guidance for radiation therapy localization This procedure uses stereoscopic X-ray imaging to precisely locate the target area for radiation therapy delivery. |
40 | $41 | $144 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
37 | $15 | $56 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
37 | $75 | $298 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
35 | $113 | $637 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $39 | $147 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $132 | $556 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
28 | $4 | $15 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
26 | $70 | $277 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
19 | $130 | $467 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
18 | $41 | $115 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
14 | $214 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.0% high complexity
69.3% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$179,385
Total received (2018-2024)
Avg $25,626/year across 7 years
Top 1% in FL for hematology
110
Companies
1,340
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90,324 (50.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$70,109 (39.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,019 (10.0%)
Other
Charitable contributions, space rental, and other categories
$933 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$27,444
2023
$33,509
2022
$13,932
2021
$15,191
2020
$17,756
2019
$25,473
2018
$46,081
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Incyte Corporation
$25,854
E.R. Squibb & Sons, L.L.C.
$21,226
Ipsen Biopharmaceuticals, Inc
$14,277
AstraZeneca Pharmaceuticals LP
$12,978
PFIZER INC.
$12,194
F. Hoffmann-La Roche AG
$9,037
Boehringer Ingelheim International GmbH
$8,149
Bayer HealthCare Pharmaceuticals Inc.
$5,828
Janssen Biotech, Inc.
$4,648
Lilly USA, LLC
$4,012
MorphoSys, US Inc.
$3,841
GENZYME CORPORATION
$3,736
Daiichi Sankyo Inc.
$3,528
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,349
Karyopharm Therapeutics Inc.
$3,126
PharmaEssentia USA Corporation
$2,807
Novartis Pharmaceuticals Corporation
$2,583
Janssen Scientific Affairs, LLC
$2,532
AbbVie Inc.
$2,429
Athenex Pharmaceutical Division, LLC
$2,420
ABBVIE INC.
$1,970
Adaptive Biotechnologies Corporation
$1,962
Azurity Pharmaceuticals, Inc.
$1,875
AVEO Pharmaceuticals, Inc.
$1,865
Stemline Therapeutics Inc.
$1,730
Genentech USA, Inc.
$1,674
Pharmacyclics LLC, An AbbVie Company
$1,636
Celgene Corporation
$1,276
JAZZ PHARMACEUTICALS INC.
$1,244
Heron Therapeutics, Inc.
$1,207
Genentech, Inc.
$1,200
CTI BioPharma Corp.
$1,160
Amgen Inc.
$848
Eli Lilly and Company
$800
Merck Sharp & Dohme LLC
$632
Seagen Inc.
$603
Gilead Sciences, Inc.
$582
Merck Sharp & Dohme Corporation
$552
BeiGene USA, Inc.
$531
AMAG Pharmaceuticals, Inc.
$520
Boehringer Ingelheim Pharma GmbH & Co.KG
$511
Eisai Inc.
$406
Kite Pharma, Inc.
$397
GlaxoSmithKline, LLC.
$356
Astellas Pharma US Inc
$335
Octapharma USA, Inc.
$332
Blueprint Medicines Corporation
$315
EISAI INC.
$314
Foundation Medicine, Inc.
$211
EMD Serono, Inc.
$206
Takeda Pharmaceuticals U.S.A., Inc.
$192
ADC Therapeutics America, Inc.
$173
Regeneron Healthcare Solutions, Inc.
$170
Alexion Pharmaceuticals, Inc.
$159
Rigel Pharmaceuticals, Inc.
$149
Seattle Genetics, Inc.
$143
Clovis Oncology, Inc.
$136
SOBI, INC
$135
Agios Pharmaceuticals, Inc.
$134
Pharmacyclics LLC, an AbbVie Company
$120
Intuitive Surgical, Inc.
$115
Genmab U.S., Inc.
$113
Bayer Healthcare Pharmaceuticals Inc.
$109
NOVARTIS PHARMACEUTICALS CORPORATION
$100
ARRAY BIOPHARMA INC
$88
G1 Therapeutics, Inc.
$87
Taiho Oncology, Inc.
$85
TESARO, Inc.
$81
Pharmacosmos Therapeutics Inc.
$77
Exelixis Inc.
$75
Global Blood Therapeutics, Inc.
$71
Apellis Pharmaceuticals, Inc.
$69
Aurobindo Pharma USA, Inc.
$66
Lexicon Pharmaceuticals, Inc.
$65
TerSera Therapeutics LLC
$62
Kyowa Kirin, Inc.
$57
Dova Pharmaceuticals
$56
Array BioPharma Inc.
$51
Verastem, Inc.
$43
Dendreon Pharmaceuticals LLC
$38
Vanda Pharmaceuticals Inc.
$37
CSL Behring
$34
Jazz Pharmaceuticals Inc.
$31
Mirati Therapeutics, Inc.
$30
Secura Bio, Inc.
$29
ImmunoGen, Inc.
$28
Puma Biotechnology, Inc.
$26
PUMA BIOTECHNOLOGY, INC.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Telix Pharmaceuticals
$23
SERVIER PHARMACEUTICALS LLC
$20
AbbVie, Inc.
$19
TG Therapeutics, Inc.
$19
Partner Therapeutics, Inc.
$18
NanoString Technologies, Inc.
$18
Sun Pharmaceutical Industries Inc.
$17
Tempus AI, Inc
$17
R-Pharm US LLC
$16
Deciphera Pharmaceuticals Inc.
$16
Spectrum Pharmaceuticals Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
Novocure Inc.
$13
Acrotech Biopharma LLC
$12
GE HEALTHCARE
$12
Sirtex Medical Inc
$12
Teva Pharmaceuticals USA, Inc.
$12
TOLMAR Pharmaceuticals, Inc.
$11
SECURA BIO, INC.
$9
Janssen Pharmaceuticals, Inc
$6
Veracyte, Inc.
$1
Top 3 companies account for 34.2% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Afstyla · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CHANTIX · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Cinvanti · Copiktra · Cresemba · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAVRETO · GAZYVA · GILOTRIF · Gazyva · Halaven · Herceptin · Hetlioz · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · Inrebic · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Oncology · Onivyde · Oral Paclitaxel · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAXOTERE · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VIVIMUSTA · VYXEOS · Vanflyta · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology in FL.
Equivalent to $52 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
9
Per 100K population
2.3
County median income
$69,956
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hussein is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), with speaking/promotional industry engagement in the top 1% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hussein experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Hussein performed 75,480 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hussein receive payments from pharmaceutical companies?
Yes. Dr. Hussein received a total of $179,385 from 110 companies across 1,340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hussein's costs compare to other hematologists in Lady Lake?
Dr. Hussein's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hussein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Lady Lake
Browse hematologists in Lady Lake ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology